Sotera Health Company Common Stock (SHC) is a publicly traded Healthcare sector company. As of May 20, 2026, SHC trades at $15.54 with a market cap of $4.38B and a P/E ratio of 37.65. SHC moved +2.04% today. Year to date, SHC is -15.03%; over the trailing twelve months it is +21.29%. Its 52-week range spans $9.53 to $19.85. Analyst consensus is strong buy with an average price target of $22.17. Rallies surfaces SHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Sotera Health Affiliates Offer 31.8 Million Shares, Company Receives No Proceeds: Sotera Health is launching a secondary offering of 31.8 million common shares by affiliates of Warburg Pincus and GTCR, with no proceeds accruing to the company. Goldman Sachs will underwrite the deal and Sotera Health will cover all offering expenses under its amended registration rights agreement.
| Metric | Value |
|---|---|
| Price | $15.54 |
| Market Cap | $4.38B |
| P/E Ratio | 37.65 |
| EPS | $0.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.85 |
| 52-Week Low | $9.53 |
| Volume | 2.12M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.19B |
| Net Income | $117.80M |
| Gross Margin | 55.26% |
6 analysts cover SHC: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.17.